# Hawaii Lawmakers Approve Bill To Create Psychedelics Task Force > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/psychedelics-task-force-study-hawaii-legislation/ > **Published:** 2026-04-09T18:05:18-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:18-04:00 > **Clinical Summary:** Hawaii lawmakers approve psychedelics task force study to explore psilocybin and MDMA therapeutic use and regulatory frameworks. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic PsychedelicsPtsdDepressionPolicy[Clinical Trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) Why This Matters Hawaii’s formal legislative study of psilocybin and MDMA reflects the growing regulatory interest in psychedelic therapeutics following FDA breakthrough therapy designations. This structured policy approach may inform clinical access pathways as these compounds advance through Phase III trials. Clinical Summary Hawaii lawmakers have approved legislation establishing a task force to study therapeutic applications of psilocybin and MDMA. This follows FDA breakthrough therapy designations for MDMA-assisted therapy in PTSD and psilocybin therapy in treatment-resistant depression. The task force will likely examine regulatory frameworks, clinical protocols, and implementation considerations as these therapies potentially move toward approval. Current clinical evidence shows promise for both compounds in specific psychiatric conditions under controlled clinical settings. Dr. Caplan’s Take “Policy study groups don’t create clinical access, but they do signal that states are preparing for eventual therapeutic availability. Patients asking about psychedelics need to understand we’re still in the clinical trial phase—legitimate access requires enrollment in approved research protocols.” Clinical Perspective 🧠 Clinicians should be prepared for increased patient inquiries about psychedelic therapies as policy discussions expand. Current evidence supports these compounds only within structured clinical trial settings with specialized protocols and monitoring. Any therapeutic use outside approved research remains experimental and carries significant safety and legal considerations. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Hawaii%20Lawmakers%20Approve%20Bill%20To%20Create%20Psychedelics%20Task%20Force%20Charged%20With%20Stu...%20%40drcaplan&url=https%3A//www.marijuanamoment.net/hawaii-lawmakers-approve-bill-to-create-psychedelics-task-force-charged-with-studying-psilocybin-and-mdma/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.marijuanamoment.net/hawaii-lawmakers-approve-bill-to-create-psychedelics-task-force-charged-with-studying-psilocybin-and-mdma/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Hawaii%20Lawmakers%20Approve%20Bill%20To%20Create%20Psychedelics%20Task%20Force%20Charged%20With%20Stu...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.marijuanamoment.net/hawaii-lawmakers-approve-bill-to-create-psychedelics-task-force-charged-with-studying-psilocybin-and-mdma/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.marijuanamoment.net/hawaii-lawmakers-approve-bill-to-create-psychedelics-task-force-charged-with-studying-psilocybin-and-mdma/](https://www.marijuanamoment.net/hawaii-lawmakers-approve-bill-to-create-psychedelics-task-force-charged-with-studying-psilocybin-and-mdma/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news article?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news_article) - [What medical conditions are discussed in this article?](#What_medical_conditions_are_discussed_in_this_article) - [What type of treatments does this article focus on?](#What_type_of_treatments_does_this_article_focus_on) - [What policy implications are discussed?](#What_policy_implications_are_discussed) - [Who should be interested in this clinical information?](#Who_should_be_interested_in_this_clinical_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news article? This article has been assigned a #80 High Clinical Relevance rating. This indicates strong evidence or policy relevance with direct clinical implications for healthcare providers and patients. #### What medical conditions are discussed in this article? The article covers PTSD and depression as primary conditions. These are [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/) that may be treated with psychedelic therapies discussed in the content. #### What type of treatments does this article focus on? The article focuses on psychedelics as therapeutic treatments. This represents an emerging area of [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) and treatment options for mental health conditions. #### What policy implications are discussed? The article includes policy-related content regarding psychedelic treatments. This likely covers regulatory changes, legal considerations, or [healthcare policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/) updates affecting patient access to these therapies. #### Who should be interested in this clinical information? Healthcare providers, mental health professionals, and patients with PTSD or depression should find this information relevant. The high clinical relevance rating suggests direct applicability to clinical practice and [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Connecticut Senate Votes To Expand Psychedelics Pilot Program In Anticipation Of FDA Approval](https://cedclinic.com/connecticut-psychedelics-pilot-program-expansion/) Connecticut lawmakers are expanding their psychedelics pilot program, reflecting growing momentum in regulatory approaches to psychedelic therapies. [Learn More](https://cedclinic.com/connecticut-psychedelics-pilot-program-expansion/) [Largest-ever Psychedelics Study Could Advance Use in Treating Mental Health Disorders](https://cedclinic.com/largest-psychedelic-research-mental-health-advances-treatment/) A major psychedelics study aims to advance therapeutic use for mental health, highlighting clinical trial progress and research significance. [Read Study Insights](https://cedclinic.com/largest-psychedelic-research-mental-health-advances-treatment/) [Joe Rogan praises Trump's executive order on psychedelics research | Watch – MSN](https://cedclinic.com/psychedelic-research-funding-impact-trump-executive-order/) Public figures highlight federal support for psychedelics research, signaling increased acceptance and policy shifts in the field. [Watch Now](https://cedclinic.com/psychedelic-research-funding-impact-trump-executive-order/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).